IGF-I and GH stimulate Phex mRNA expression in lungs and bones and 1,25-dihydroxyvitamin D3 production in hypophysectomized rats

European Journal of Endocrinology

Volumn 146, Issue 1, 2002, Pages 97-105

  Zoidis, Evangelos ^a   Gosteli Peter, Martina ^a   Ghirlanda Keller, Claudia ^a   Meinel, Lorenz ^a   Zapf, Jürgen ^a   Schmid, Christoph ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE; CALCIFEDIOL; CALCITRIOL; DRUG VEHICLE; GROWTH HORMONE; MEMBRANE METALLOENDOPEPTIDASE; MESSENGER RNA; OSTEOCALCIN; OXYGENASE; PHOSPHATE; PROTEIN PHEX; PROTEINASE; SODIUM; SOMATOMEDIN C; UNCLASSIFIED DRUG; VITAMIN D; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE; BONE GROWTH; CONTROLLED STUDY; EPIPHYSIS; GENE EXPRESSION; HORMONE ACTION; HYPOPHYSECTOMY; KIDNEY; LUNG; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PHOSPHATE TRANSPORT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FAMILY; RAT; REGULATORY MECHANISM; TIBIA; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM;

EID: 0036164163     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1460097     Document Type: Article

References (56)

1. Mendelian Hypophosphatemias
2. Catalogs of autosomal dominant, autosomal recessive, and X-linked phenotypes
3. PHEX gene and hypophosphatemia
4. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease
5. Hypophosphatemia: Mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets
6. Cloning and sequencing of human PEX from a bone cDNA library: Evidence for its developmental stage-specific regulation in osteoblasts
7. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets
8. cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone
9. Pex/PEX tissue distribution and evidence for a deletion in the 3′ region of the Pex gene in X-linked hypophosphatemic mice
10. Cloning of human PEX cDNA expression, subcellullar localization, and endopeptidase activity
11. Pex mRNA is localized in developing mouse osteoblasts and odontoblasts
12. Phex cDNA cloning from rat bone and studies on phex mRNA expression: Tissue-specificity, age-dependency, and regulation by insulin-like growth factor (IGF) I in vivo
13. Renal Na(+)-phosphate cotransport in murine X-linked hypophosphatemic rickets. Molecular characterization
14. Effect of P(i) restriction on renal Na(+)-P(i) cotransporter mRNA and immuno-reactive protein in X-linked Hyp mice
15. Abnormal vitamin D metabolism in the X-linked hypophosphatemic mouse
16. Abnormal regulation of renal vitamin D catabolism by dietary phosphate in murine X-linked hypophosphatemic rickets
17. 2D concentrations in response to dietary phosphate deprivation in hypophysectomized rats
18. Abnormal relationship between serum phosphate concentration and renal 25-hydroxycholecalciferol-1-alpha-hydroxylase activity in X-linked hypophosphatemic mice
19. Increased plasma 1,25-dihydroxyvitamin D after low calcium challenge in X-linked hypophosphatemic mice
20. +-phosphate cotransporter (Npt2) mRNA in phosphate-deprived Hyp mice
21. The effects of bone marrow transplantation on X-linked hypophosphatemic mice
22. Renal threshold phosphate concentration (TmPO4/GFR)
23. Effects of hypophysectomy and growth hormone treatment on renal hydroxylation of 2 5-hydroxycholecalciferol in rats
24. Activation of renal 1,25-dihydroxyvitamin D3 synthesis by phosphate deprivation: Evidence for a role for growth hormone
25. Hormonal control of growth
26. Bioassay of hypophyseal growth hormone; tibia test
27. Insulin-like growth factor I regulates type I procollagen messenger ribonucleic acid steady state levels in bone of rats
28. Isolation and analysis of ribonucleic acids from skeletal tissues
29. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
30. Real time quantitative PCR
31. Quantitative real-time PCR for equine cytokine mRNA in nondecalcified bone tissue embedded in methyl methacrylate
32. 3
33. Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF-I) in normal rats
34. Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo
35. Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats
36. Insulin-like growth factor (IGF) and IGF-binding proteins: Comparison of human serum and lymph
37. Insulin-like growth factors I and II in healthy man Estimations of half-lives and production rates
38. The endocrine/paracrine actions of IGFs on bone
39. Targeted overexpression of insulin-like growth factor I to osteobiasts of transgenic mice: Increased trabecular bone volume without increased osteoblast proliferation
40. ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1
41. Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX
42. Molecular cloning and biochemical characterization of a new mouse testis soluble-zinc-metallopeptidase of the neprilysin family
43. Developmental expression and tissue distribution of phex protein: Effect of the Hyp mutation and relationship to bone markers
44. 3 down-regulates expression of Phex, a marker of the mature osteoblast
45. X-linked hypophosphataemia: A homologous disorder in humans and mice
46. Intestinal Ca and phosphate transport: Differential responses to vitamin D3 metabolites
47. Intestinal absorption of calcium: Role of dietary phosphate and vitamin D
48. The response of intestinal calcium transport to 25-hydroxy and 1,25-dihydroxy vitamin D in nephrectomized rats
49. Calcitonin is a major regulator for the expression of renal 25-hydroxyvitamin D3-1alpha-hydroxylase gene in normocalcemic rats
50. Local action of exogenous growth hormone and insulin-like growth factor-I on dihydroxyvitamin D production in LLC-PK1 cells
51. Local action of phosphate depletion and insulin-like growth factor 1 on in vitro production of 1.25-dihydroxyvitamin D by cultured mammalian kidney cells
52. Insulin-like growth factor I, a unique calcium-dependent stimulator of 1.25-dihydroxyvitamin D3 production. Studies in cultured mouse kidney cells
53. Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1.25-dihydroxycholecalciferol in GH-deficient adults
54. Regulation of renal vitamin D-24-hydroxylase by phosphate: Effects of hypophysectomy, growth hormone and insulin-like growth factor I
55. Growth hormone increases serum 1,25-dihydroxyvitamin D levels and decreases 24,25-dihydroxyvitamin D levels in children with growth hormone deficiency